Literature DB >> 32566908

Characterization of the Core Ribosomal Binding Region for the Oxazolidone Family of Antibiotics Using Cryo-EM.

Alexander Wright1, Kieran Deane-Alder2, Edward Marschall3, Rebecca Bamert4, Hari Venugopal5, Trevor Lithgow4, David W Lupton1, Matthew J Belousoff2.   

Abstract

Linezolid and tedizolid are oxazolidinones with established clinical utility for the treatment of Gram-positive pathogens. Over time it has become apparent that even modest structural changes to the core phenyl oxazolidinone leads to drastic changes in biological activity. Consequently, the structure-activity relationship around the core oxazolidinone is constantly evolving, often reflected with new structural motifs present in nascent oxazolidinones. Herein we describe the use of cryo-electron microscopy to examine the differences in binding of several functionally different oxazolidinones in the hopes of enhanced understanding of their SAR. Tedizolid, radezolid, T145, and contezolid have been examined within the peptidyl transferase center (PTC) of the 50S ribosomal subunit from methicillin resistant Staphylococcus aureus. The ribosome-antibiotic complexes were resolved to a resolution of around 3 Å enabling unambiguous assignment of how each antibiotic interacts with the PTC.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32566908      PMCID: PMC7296538          DOI: 10.1021/acsptsci.0c00041

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  33 in total

1.  Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus.

Authors:  Zohar Eyal; Donna Matzov; Miri Krupkin; Itai Wekselman; Susanne Paukner; Ella Zimmerman; Haim Rozenberg; Anat Bashan; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-13       Impact factor: 11.205

2.  Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function.

Authors:  Shawn Flanagan; Edward E McKee; Debaditya Das; Paul M Tulkens; Hiromi Hosako; Jill Fiedler-Kelly; Julie Passarell; Ann Radovsky; Philippe Prokocimer
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

3.  Thrombocytopenia with Tedizolid and Linezolid.

Authors:  Erica Yookyung Lee; Aisling R Caffrey
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis.

Authors:  Eva E Nagiec; Luping Wu; Steve M Swaney; John G Chosay; Daniel E Ross; Joan K Brieland; Karen L Leach
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Synthesis of novel oxazolidinone antimicrobial agents.

Authors:  David C Ebner; Jeffrey C Culhane; Tyler N Winkelman; Mitchell D Haustein; Jayna L Ditty; J Thomas Ippoliti
Journal:  Bioorg Med Chem       Date:  2007-11-19       Impact factor: 3.641

Review 6.  Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.

Authors:  Claire Roger; Jason A Roberts; Laurent Muller
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

Review 7.  Recent developments in the identification of novel oxazolidinone antibacterial agents.

Authors:  Adam R Renslo; Gary W Luehr; Mikhail F Gordeev
Journal:  Bioorg Med Chem       Date:  2006-03-09       Impact factor: 3.641

8.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

9.  New tools for automated high-resolution cryo-EM structure determination in RELION-3.

Authors:  Jasenko Zivanov; Takanori Nakane; Björn O Forsberg; Dari Kimanius; Wim Jh Hagen; Erik Lindahl; Sjors Hw Scheres
Journal:  Elife       Date:  2018-11-09       Impact factor: 8.140

10.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix.

Authors:  Dorothee Liebschner; Pavel V Afonine; Matthew L Baker; Gábor Bunkóczi; Vincent B Chen; Tristan I Croll; Bradley Hintze; Li Wei Hung; Swati Jain; Airlie J McCoy; Nigel W Moriarty; Robert D Oeffner; Billy K Poon; Michael G Prisant; Randy J Read; Jane S Richardson; David C Richardson; Massimo D Sammito; Oleg V Sobolev; Duncan H Stockwell; Thomas C Terwilliger; Alexandre G Urzhumtsev; Lizbeth L Videau; Christopher J Williams; Paul D Adams
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-10-02       Impact factor: 7.652

View more
  6 in total

1.  Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.

Authors:  Kaitlyn Tsai; Vanja Stojković; D John Lee; Iris D Young; Teresa Szal; Dorota Klepacki; Nora Vázquez-Laslop; Alexander S Mankin; James S Fraser; Danica Galonić Fujimori
Journal:  Nat Struct Mol Biol       Date:  2022-02-14       Impact factor: 18.361

2.  In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe.

Authors:  Cecilia G Carvalhaes; Leonard R Duncan; Wen Wang; Helio S Sader
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

3.  Mechanistic Insights into the Capsule-Targeting Depolymerase from a Klebsiella pneumoniae Bacteriophage.

Authors:  Rhys A Dunstan; Rebecca S Bamert; Matthew J Belousoff; Francesca L Short; Christopher K Barlow; Derek J Pickard; Jonathan J Wilksch; Ralf B Schittenhelm; Richard A Strugnell; Gordon Dougan; Trevor Lithgow
Journal:  Microbiol Spectr       Date:  2021-08-25

Review 4.  Strategies to Improve the Potency of Oxazolidinones towards Bacterial Biofilms.

Authors:  Audrey R N Ndukwe; Sandra Wiedbrauk; Nathan R B Boase; Kathryn E Fairfull-Smith
Journal:  Chem Asian J       Date:  2022-04-13

5.  Compassionate Use of Contezolid for the Treatment of Tuberculous Pleurisy in a Patient with a Leadless Pacemaker.

Authors:  Yixin Kang; Cheng Ge; Huan Zhang; Saizhe Liu; Hongyang Guo; Junchang Cui
Journal:  Infect Drug Resist       Date:  2022-08-12       Impact factor: 4.177

6.  A Structurally Characterized Staphylococcus aureus Evolutionary Escape Route from Treatment with the Antibiotic Linezolid.

Authors:  Laura Perlaza-Jiménez; Kher-Shing Tan; Sarah J Piper; Rachel M Johnson; Rebecca S Bamert; Christopher J Stubenrauch; Alexander Wright; David Lupton; Trevor Lithgow; Matthew J Belousoff
Journal:  Microbiol Spectr       Date:  2022-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.